Clinical trial
A Phase 2 Study of E7080 in Subjects With Advanced Thyroid Cancer
NCT01728623 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Study of E7080 in Subjects With Advanced Thyroid Cancer
- Lead sponsor
- Eisai Co., Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 3, 2012
- Completion date
- October 1, 2015
- Enrollment
- 51 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
thyroid cancer